Seoul
South Korea
2
2024-05-16
2
2025-12-23
These are the the leading inventors for applications assigned to Celros Biotech:
Celros Biotech based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
SH3YL1 Antibodies, Compositions Comprising the Same, and Vectors and Uses Thereof
#2 | 2022-03-31 ✅ Patent 11,845,790 granted on 2023-12-19SH3YL1 antibodies, compositions comprising the same, and vectors and uses thereof
Also check out Celros Biotech's (Seoul, South Korea) applicant profile with 3 patent applications submitted.
608206 ⎘